Full Press Release Details
SS Innovations International, Inc. (f/k/a Avra
Medical Robotics, Inc.)
Commences Trading under "SSII" Ticker Symbol and Provides Corporate Update
SSII is a Developer of Innovative, Affordable
and Accessible Surgical Robotic Technologies
Ft Lauderdale, Florida - May 15, 2023 -
SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer of innovative
surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the
global population, today released a corporate update.
Dr. Sudhir Srivastava, Chairman of the Board and
Chief Executive Officer of SS Innovations, commented, "We are very excited to begin trading in the United States on OTC Markets
under the ticker symbol "SSII", the initials of the company that I founded over 10 years ago. SS Innovations has a vision
to make the benefits of robotic surgery affordable and accessible to a larger part of the global population, and we are now in a stronger
position to make that happen with this foothold in the American capital markets. With our flagship "SSI Mantra" Surgical Robotic
System, we have now trained over 50 robotic surgeons, completed over 180 surgeries across multiple specialties on six system installations,
and have a rapidly growing pipeline of system orders, initially in India. Other milestones we expect to reach this year include, the development
of Mixed Reality based Robotic Surgery Applications for teaching, training, patient education and portable telesurgery. We are also developing
a comprehensive robotic surgery ecosystem to centralize patients, surgeons, proctors, clinical engineers, field service technicians, radiology
centers, and other key beneficiaries to provide a seamless adoption of robotic surgery around the world for basic surgical healthcare.
The systems have obtained all necessary medical device regulatory and commercialization approvals in India, which are also acceptable
in many other countries with certain registration processes, and will plan on commencing the FDA and CE approval processes this year.
With a strong foundation in place, we look forward to meeting the growing need around the world for our cutting edge and cost effective
robotic surgical systems."
About SS Innovations International, Inc.
SS Innovations International, Inc. (OTC: SSII)
is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible
to a larger part of the global population. SSII's product range includes its proprietary "SSI Mantra" surgical robotic
system, and "SSI Mudra" is its wide range of surgical instruments capable of supporting a variety of surgical procedures including
robotic cardiac surgery. SSII's business operations are headquartered in India and SSII has plans to expand the presence of its
technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII's
website at www.ssinnovations.com
Forward-Looking Statements
This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words "anticipate," "assume," "believe," "estimate," "expect," "will,"
"intend," "may," "plan," "project," "should," "could," "seek,"
"designed," "potential," "forecast," "target," "objective," "goal,"
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or AVRA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause
our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity,
performance or achievements expressed or implied by these forward-looking statements.
For Further Information Contact: